Index Ventures Growth II (Jersey), L.P.
CIK: 0001736959
Associated companies
Transaction History
| WLTH | ▼ Sell | Other | 2,669 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 2,370,596 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 779,009 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 207,734 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 35,007 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 11,528 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 3,074 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 2,876,772 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 2,913,888 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 58,068 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 58,816 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 37,148 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 37,629 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 30,450 | — | 12/15/2025 | View on chart |
| WLTH | ▼ Sell | Other | 10,007 | — | 12/15/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Wealthfront Faces Scrutiny Over Post-IPO Disclosures
Wealthfront is currently under scrutiny regarding its post-IPO disclosures, which has drawn attention from market participants. While some analysis suggests the stock may be undervalued following recent asset growth news, the company's share price remains below the average analyst target. The stock is trading near its 52-week high, reflecting mixed sentiment amid these regulatory questions.
Wealthfront Faces Scrutiny Over Post-IPO Disclosures. Wealthfront is currently under scrutiny regarding its post-IPO disclosures, which has drawn attention from market participants. While some analysis suggests the stock may be undervalued following recent asset growth news, the company's share price remains below the average analyst target. The stock is trading near its 52-week high, reflecting mixed sentiment amid these regulatory questions.